Growth in US Orbem is expanding into the United States with plans to scale poultry solutions and extend its platform to new verticals such as food quality inspection and healthcare, signaling strong cross‑sell opportunities with North American agriculture, pharmaceuticals, and consumer brands.

Genus Scale Promise The launch of Genus Scale enables inside eggs assessment to check fertilization status before incubation, opening direct sales avenues with egg producers, hatcheries, and related supply chains seeking non‑invasive, rapid quality insights.

Finance & Validation Recent Series B funding of over fifty million euros and total funding of about one hundred million dollars validate investor confidence and provide capital to accelerate sales efforts, especially in the US market and new verticals.

Industry Partnerships Existing collaborations with leaders like Hendrix Genetics demonstrate a track record of enterprise partnerships in breeding and genetics, offering a blueprint for scaling enterprise deals with other large agricultural and health players.

Sustainability Angle Orbem’s non‑destructive, AI‑driven MRI analyses reduce waste and increase quality across agriculture, food, and health, creating a compelling sustainability story to win contracts with ESG‑focused brands and government programs.